Seller record · Telehealth service

Layla

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy. The pages say a prescription is sent to a partner pharmacy, and the terms name only a pharmacy network. 2 more criteria also fail; see the table below.

At a glance

LaylaTelehealth service

5/8criteria passed

Price: Ozempic $1,399 a month, $100 off a listed $1,499; sermorelin $177 first month, then $227
Sells: brand Ozempic, brand Wegovy, brand Zepbound, and 5 more
FDA letters: None on file

Visit Layla See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A Miami telehealth service selling brand Ozempic, Wegovy, Zepbound and Mounjaro on monthly plans, with compounded sermorelin, NAD+, glutathione and MIC with B12 injections. Physicians of a named medical group prescribe, and no filling pharmacy is named.

Operating entity Dynamic Trading Enterprises LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Layla's start online visit page on its app site; Layla's terms and conditions
S2	Prescription gating	PASS	Layla's start online visit page on its app site; Layla's sermorelin page on its app site; Layla's FAQ
S3	Pharmacy identification	FAIL	Layla's sermorelin page; Layla's FAQ; Layla's terms and conditions
S4	Compounding disclosure	FAIL	Layla's sermorelin page; Layla's NAD+ page
S5	Analytical documentation	FAIL	Layla's sermorelin page; Layla's terms and conditions
S6	Business address	PASS	Layla's privacy policy; Layla's terms and conditions; Layla's code of conduct page
S7	Price disclosure	PASS	Layla's ozempic page; Layla's all treatments page; Layla's FAQ; Layla's sermorelin page; Layla's NAD+ page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSBoard-certified physicians carry out the medical evaluation and prescribe, and the terms state that care comes from providers employed or contracted by Beluga Health, P.A.Source: Layla's start online visit page on its app site; Layla's terms and conditions.

S2PASSThe weight loss start button opens a visit that collects basic information, lifestyle and medical history for a doctor to decide eligibility, and a buyer who does not qualify is refunded in full. The sermorelin button opens an email and account screen with no cart and no payment form.Source: Layla's start online visit page on its app site; Layla's sermorelin page on its app site; Layla's FAQ.

S3FAILThe site names no filling pharmacy. The pages say a prescription is sent to a partner pharmacy, and the terms name only a pharmacy network.Source: Layla's sermorelin page; Layla's FAQ; Layla's terms and conditions.

S4FAILThe sermorelin page sells compounded sermorelin with no statement that it is not FDA-approved, and every product page describes the treatments as made with FDA approved ingredients.Source: Layla's sermorelin page; Layla's NAD+ page.

S5FAILNo certificate of analysis or lot document is published on the product pages, the answers or the terms.Source: Layla's sermorelin page; Layla's terms and conditions.

S6PASSDynamic Trading Enterprises LLC at 3250 NE 1st Ave Unit 305, Miami, FL 33137, printed in the privacy policy. The terms print the same building as Suite 305, and the code of conduct gives it with no unit.Source: Layla's privacy policy; Layla's terms and conditions; Layla's code of conduct page.

S7PASSOzempic at $1,399 a month, marked $100 off a listed $1,499, with Wegovy at $1,699 and Mounjaro at $1,399 on the treatments page, while the answers page says GLP-1 medication starts at $1,299. Sermorelin at $177 for the first month and $227 a month after, which the page calls the regular price. The NAD+ injection at $249 a month or $199 a month on the quarterly plan, glutathione at $149 or $119, and MIC with B12 at $129 or $99.Source: Layla's ozempic page; Layla's all treatments page; Layla's FAQ; Layla's sermorelin page; Layla's NAD+ page.

S8PASSNo FDA warning letter names Layla or Dynamic Trading Enterprises LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: brand Ozempic, brand Wegovy, brand Zepbound, brand Mounjaro, compounded sermorelin, NAD+ injection, glutathione injection, lipotropic MIC and B12 injection.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione

Visit Layla

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.